Sunday, January 17, 2016 2:53:03 PM
Amphastar filed a brief requesting a rehearing. I just glanced at it, will read it more careful soon. But on a five minute review, it seems to be a rehash of old arguments. Here is a link to the brief.
https://www.dropbox.com/s/g9flccxms03spjv/Amphastar%20hearing%20petition.pdf?dl=0
In theory, Momenta also had the right to petition for a rehearing, they might've done that with respect to the Teva part of the decision (TEVA prevailed on the independent ground that they manufacture outside the US and arguably the statute language requires that the infringed patent be used to "make" the product -- at least that's my recollection of the Court's holding). But Momenta did not file a petition.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM